AI-generated summary
The authors report a triple-blinded randomized trial of delayed photobiomodulation therapy in patients with inferior alveolar nerve neurotmesis after mandibular fracture, comparing active laser with a sham control over 12 sessions. They report significant improvement in several light touch and two-point discrimination measures in the treatment group, with no significant difference in electric pulp and thermal tests, and conclude that the therapy could be effective.
- Who or what was studied
- Patients with inferior alveolar nerve neurotmesis at least 6 months after mandibular angle and body fracture
- Wavelengths
- 810 nm
- Limits stated in the abstract
- The abstract reports a small sample of 26 patients split across two groups and does not describe a control-group comparison of all outcomes, so the effectiveness conclusion rests on limited evidence.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 810 nm
- Energy density (fluence)
- 14 J/cm2
- Power
- 200 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Laser, Low-level laser therapy, Control group, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.